1. Home
  2. GKOS vs NOV Comparison

GKOS vs NOV Comparison

Compare GKOS & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • NOV
  • Stock Information
  • Founded
  • GKOS 1998
  • NOV 1862
  • Country
  • GKOS United States
  • NOV United States
  • Employees
  • GKOS N/A
  • NOV N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • NOV Metal Fabrications
  • Sector
  • GKOS Health Care
  • NOV Industrials
  • Exchange
  • GKOS Nasdaq
  • NOV Nasdaq
  • Market Cap
  • GKOS 5.4B
  • NOV 4.9B
  • IPO Year
  • GKOS 2015
  • NOV 1996
  • Fundamental
  • Price
  • GKOS $84.11
  • NOV $13.68
  • Analyst Decision
  • GKOS Strong Buy
  • NOV Buy
  • Analyst Count
  • GKOS 13
  • NOV 17
  • Target Price
  • GKOS $121.46
  • NOV $16.65
  • AVG Volume (30 Days)
  • GKOS 864.7K
  • NOV 3.9M
  • Earning Date
  • GKOS 11-03-2025
  • NOV 10-27-2025
  • Dividend Yield
  • GKOS N/A
  • NOV 2.21%
  • EPS Growth
  • GKOS N/A
  • NOV N/A
  • EPS
  • GKOS N/A
  • NOV 1.21
  • Revenue
  • GKOS $432,953,000.00
  • NOV $8,790,000,000.00
  • Revenue This Year
  • GKOS $28.90
  • NOV N/A
  • Revenue Next Year
  • GKOS $25.57
  • NOV $0.16
  • P/E Ratio
  • GKOS N/A
  • NOV $11.20
  • Revenue Growth
  • GKOS 26.70
  • NOV N/A
  • 52 Week Low
  • GKOS $77.10
  • NOV $10.84
  • 52 Week High
  • GKOS $163.71
  • NOV $16.86
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.81
  • NOV 58.63
  • Support Level
  • GKOS $79.02
  • NOV $13.17
  • Resistance Level
  • GKOS $89.29
  • NOV $13.91
  • Average True Range (ATR)
  • GKOS 3.19
  • NOV 0.39
  • MACD
  • GKOS 0.54
  • NOV 0.05
  • Stochastic Oscillator
  • GKOS 49.76
  • NOV 84.49

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About NOV NOV Inc.

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

Share on Social Networks: